Meeting
2012 ASCO Annual Meeting
Allogeneic stem cell transplantation for patients over age 65 with acute myelogenous leukemia and myelodysplastic syndrome.
Authors
Henry Jacob Conter
University of Texas M. D. Anderson Cancer Center, Houston, TX
Henry Jacob Conter , Gabriela Rondon , Nhu-Nhu Nguyen , Julianne Chen , Elizabeth J. Shpall , Issa F. Khouri , Sergio Giralt , Richard E. Champlin , Marcos J.G. De Lima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Allogeneic Bone Marrow
Citation
J Clin Oncol 30, 2012 (suppl; abstr 6529)
DOI
10.1200/jco.2012.30.15_suppl.6529
Abstract #
6529
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Analysis of outcomes in patients (pts) with relapsed/refractory acute promyelocytic leukemia (APL) treated with and without high-dose chemotherapy and hematopoietic stem cell transplantation (HCT).
First Author: N. Pemmaraju
Poster
2023 ASCO Annual Meeting
Myeloablative fractionated busulfan-based conditioning regimen in patients with AML and MDS: Results of a randomized clinical trial comparing 2 fractionation schedules.
First Author: Uday R. Popat
Poster
2014 ASCO Annual Meeting
Haploidentical transplantation (HaploSCT) with post-transplant cyclophosphamide (PTCy) and melphalan-based conditioning: A retrospective analysis of the first 100 patients treated at MD Anderson Cancer Center.
First Author: Piyanuch Kongtim
Poster
2011 ASCO Annual Meeting
A randomized, phase III trial comparing BuCy and BuFlu as a myeloablative conditioning regimen.
First Author: S. Kim